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ABSTRACT  
The aim of the present study was to develop timed delayed capsule device of terbutaline sulphate 
intended for chronotherapy. A time delayed capsule was prepared by sealing the drug tablet and the 
expulsion excipient inside the insoluble hard gelatin capsule body with erodible tablet plug. The 
erodible tablets were prepared by direct compression. Influence of formulation factors such as type of 
plug material, different plug composition, erodible tablet weight and hardness was investigated to 
characterize the lag time (t10). The results indicated that drug release from the time delayed capsule 
exhibited an initial lag period, followed by a stage of rapid drug release. Erodible tablet plugs prepared 
using higher molecular weight of polyethylene oxide resulted in longer lag times. A good correlation 
was observed between erodible tablet weight and lag time. In accordance with the chronomodulated 
therapy of asthma the lag time criterion of 5hrs was satisfied by formulation containing 90mg of WSR 
N-10 (low molecular weight polyethylene oxide) in the erodible tablet plug. 
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INTRODUCTION 
A time delayed release profile is characterized by a lag time followed by rapid and complete drug 
release
1.Several approaches to delay drug release exists. Some systems contain a drug reservoir, 
surrounded by a barrier which either erodes or dissolves
2,3 or ruptures
4,5. With eroding or dissolving 
systems, a potential problem is the retardation and therefore not immediate drug release after the loss 
of the barrier function or a premature release seen in particular with highly water soluble drugs. 
Capsular-shaped systems are more independent from the nature of the content
6 and system consists of 
an insoluble capsule body with swellable
7 or erodible tablet plugs
8 have been reported. 
Based on chronopharmacology, many common clinical diseases like bronchial asthma, myocardial 
infarction, angina pectoris, rheumatic disease, ulcer and hypertension display significant circadian 
variation in onset or exacerbation of symptoms
9,10. A review of the chronobiology of asthma 
highlighted that airway resistance, bronchoconstriction, exacerbation of symptoms and worsening of 
lung function, increase progressively at night. It has been reported that risk of asthma attacks is l00 
fold greater during the night time hours (around 2.00 am) than during other times of day, an 
observation which has nicely been confirmed in modern epidemiologic studies in asthmatic patient
11,12. 
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Terbutaline sulphate, a potent β2 receptor stimulant and has been effective for preventing time related 
occurrence of asthma
13.In the light of the chronobiologic and chronopathologic findings, this study 
attempts to design and evaluate time delayed capsule of terbutaline sulphate, consisting of insoluble 
hard gelatin capsule body, which contains the drug tablet and is closed by an erodible tablet plug 
(Figure 1). It was aimed to have a lag time of five hours i.e., the system is taken at bed time and 
expected to release the drug after a period of 5h (around 2.00 am) when the asthma attacks are more 
prevalent. The lag time (t10) was defined as intersection point on the time axis when 10% of the drug 
contained was released. Effect of various formulations parameters such as type of plug material, 
different plug composition, plug weight and plug hardness was investigated to characterize the lag 
time. 
Figure 1: Assembly of timed delayed capsule device 
 
MATERIALS AND METHODS 
Materials 
Terbutaline sulphate was obtained as gift sample from Sehat Pharma Ltd, Himatnagar. Three different 
molecular weights of polyethylene oxide (PEO) WSR N-10(MW 100,000), PEO WSR N-80(MW 
200,000), and PEO WSR N-750 (MW 300,000) were obtained as gift sample from Coloron Asia Ltd. 
Avicel (microcrystalline cellulose pH102) and spray dried lactose were obtained as gift sample from 
Cipla Ltd, Mumbai. Low substituted hydroxypropylcellulose (HPC-L) was obtained as gift sample 
from Nippon Soda Japan. Sodium starch glycolate (SSG), magnesium stearate, and talc were 
purchased from S. D. Fine chemicals Ltd. Mumbai. All other chemicals were laboratory grade. 
Methods 
Drug excipient compatibility studies 
Infrared spectra were taken by using KBr pellet technique using a Shimadzu FTIR 8300 
Spectrophotometer (Shimadzu, Tokyo, Japan) in the wavelength region of 4000 to 400 cm−1. The 
procedure consisted of dispersing a sample (pure drug or mixture of drug and excipients or only 
excipients) in KBr and compressing into discs by applying a pressure of 5 tons for 5 min in a hydraulic 
press. The pellet was placed in the light path and the spectrum was obtained. 
Preparation of impermeable/insoluble capsule body 
The body and the cap of the hard gelatin capsules (size 0) were separated.  Capsule bodies was 
exposed to formaldehyde vapors for six hours at room temperature and dried at 50 
oC for 12 hours in 
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hot air oven
14. Afterwards the capsule body and the untreated soluble cap were stored in desiccators 
for further use. The efficacy of the treated capsules was checked by a disintegration (Model 
Electrolab-ED2, Mumbai) test
15. 
Preparation of terbutaline sulphate tablets 
Terbutaline sulphate tablets (5mg/tablet) were prepared by direct compression method having the 
following composition: Terbutaline sulphate 6.25%, Avicel 88.75%, SSG 2%, talc 1%, and 
magnesium stearate 2%. All the ingredients except magnesium stearate were dry blended for 10 min. 
Magnesium stearate was added and then further blended for additional 5 minutes. The resultant 
mixture was tableted to 80mg using 5mm flat-faced punches using a rotary tablet machine (Cadmach 
Machinery, India). The tablets were evaluated for the different physicochemical parameters such as 
hardness, friability, weight variation, drug content and disintegration time.
   
Preparation of erodible tablet plug 
Direct compression method was used to prepare the erodible tablet plug. The compositions of different 
the erodible tablet plugs used were as shown in Table 1. The plug ingredients (PEO and spray dried 
lactose) were mixed for 10 minutes. Magnesium stearate (1%) was added to the previous mixture and 
further blended for 5 minutes and compressed using single punch tablet machine. (Cadmach, 
Machines Ltd Ahmedabad, India).The diameter of the tablet plug was 7mm and the weight was varied 
between 110-190mg.  
Table 1: Composition of different erodible tablet plugs 
Batch code 
WSR 
N10 
WSR 
N80 
WSR 
N750 
Lactose 
Magnesium 
stearate 
Total 
weight 
A1  30  -  -  118.5  1.5  150 
A2  -  30  -  118.5  1.5  150 
A3  -  -  30  118.5  1.5  150 
A4  -  25.5  -  123  1.5  150 
A5  -  -  25.5  123  1.5  150 
A6  45  -  -  103.5  1.5  150 
A7  60  -  -  88.5  1.5  150 
A8  75  -  -  73.5  1.5  150 
A9  90  -  -  58.5  1.5  150 
A10  105  -  -  43.5  1.5  150 
                Note: All the quantities expressed in milligrams. 
Time delayed capsule assembly  
Assembly of delayed release capsule device proceeded as follows (Figure 1); L-HPC (150 mg) was 
weighed into the bottom of impermeable capsule body and lightly compacted. Terbutaline sulphate 
tablet was placed onto the compacted L-HPC layer. An erodible tablet plug was inserted into the 
mouth of the capsule so that upper surface of the erodible tablet flushed with the open end of the 
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capsule body. The erodible tablet plug fitted snuggly with the wall of the capsule. Finally the soluble 
capsule cap was placed over the impermeable capsule body. 
Dissolution studies of time delayed capsule device 
The dissolution study of time delayed capsule was carried out using USP Type II apparatus (model 
VDA-6D, Veego Ltd Mumbai) at 37 ± 0.5 
oC and paddle speed of 50rpm. First 900ml of buffer pH 1.2 
was used as dissolution medium up to 2 hours. There after the dissolution medium was replaced by 
phosphate buffer (pH 6.8) and the dissolution test was continued in the new medium. Aliquots of the 
dissolution medium were removed at different time intervals and amount of terbutaline sulphate 
released was estimated by spectrophotometrically
16. Each dissolution data point represents the mean of 
at least three individual trials in Figures 3-6. 
RESULTS AND DISCUSSION  
Drug excipient interaction studies 
Figure 2: (a) Terbutaline sulphate alone. (b) Drug–excipient mixture. (c) Excipient mixture alone 
 
The FTIR spectra of pure terbutaline sulphate and its physical mixture with other excipients and only 
excipient are shown in Figure 2. Pure terbutaline sulphate showed major peaks at 3335cm
- 
1(OH 
stretch), 3057cm
–1(aromatic CH stretch), 2974cm
–1(methyl asymmetric stretch), 1608&1485cm
–
1(aromatic ring stretch), 1380(t-butyl symmetric bend), 1068cm
–1(secondary alcohol stretch. The 
results revealed no considerable changes in the IR peak of terbutaline sulphate in the prepared 
formulation when compared to pure drug, thereby indicating the absence of any interaction. 
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Physicochemical Characterization of terbutaline sulphate tablets  
Terbutaline sulphate tablets were prepared by direct compression method. For direct compression of 
materials, it is required to possess good flow and compacting properties. Therefore tablet powder 
blend was studied for angle of repose, Carr's index and Hausner ratio. Values for angle of repose 20–
30° generally indicate good flow property. A Hausner ratio of less than 1.25 and Carr's index of 12–16 
indicate good flow. The angle of repose, Carr's index and Hausner ratio was found to be 27.64±0.8°, 
15.55±1.2%, and 1.18 ±0.01 respectively. The average weight of the tablets was 80±4mg. Hardness, 
friability, drug content and disintegration time of terbutaline sulphate tablets was 3.50±0.19 kg/cm
2, 
0.65%, 98.4±3.3% and 2minutes respectively.  
Formaldehyde treatment of hard gelatin capsule 
Gelatin is readily soluble in biological fluids at body temperature. Formaldehyde and heat treatment 
was employed to modify the solubility of the hard gelatin capsule. The treated capsules were subjected 
to disintegration test. The results revealed that all the six capsule caps disintegrated and solubilized 
within 25 minutes in the disintegration tests of empty capsules, while the formaldehyde treated body 
of the capsule remained intact for more than 12 hrs. Thus drug will be released from a limited surface 
area of open end of the hard gelatin capsule body, which indicates the suitability for timed delayed 
released dosage form. 
Physicochemical Characterization of erodible tablet plug   
Different erodible tablet plugs were also prepared by direct compression method. The results of 
micromeritic properties are presented in Table 2.Tablet plugs were studied for hardness, friability and 
weight variation. The average weight of the tablet plugs was found to be 150±3.5mg respectively. The 
friability of all the tablets was below 1%. 
Table 2: Physicochemical characterization and micromeritics properties of various erodible tablet 
plugs 
Batch 
code 
Angle of 
repose 
Carr’s 
index  
Hausner 
ratio 
Hardness 
Kg/cm
2
Friability 
(%) 
Weight 
variation 
(%) 
A1  20.05±1.3  12.50±0.25  1.14±0.010  4.1±0.28  0.82  ± 2.3 
A2  23.64±1.7  11.11±1.06  1.12±0.015  5.0±0.5  0.76  ± 1.1 
A3  24.03±1.4  14.70±0.32  1.17±0.020  5.6±0.76  0.53  ± 3.0 
A4  22.96±0.6  12.72±1.2  1.14±0.005  4.8±0.5  0.22  ± 2.2 
A5  25.43±0.8  13.55±0.51  1.15±0.015  5.1±0.5  0.19  ± 2.0 
A6  17.34±1.5  15.06±0.9  1.17±0.005  4.8±0.76  0.14  ± 1.5 
A7  21.21±1.2  15.6±0.23  1.21±0.036  5.0±0.5  0.21  ± 3.5 
A8  19.30±1.6  14.80±1.03  1.18±0.020  5.3±0.28  0.34  ± 2.7 
A9  23.35±1.3  16.28±0.73  1.20±0.025  5.6±0.28  0.27  ± 2.5 
A10  24.46±0.4  17.18±0.53  1.22±0.010  5.8±0.5  0.39  ± 3.0 
 
Ars Pharm, Vol. 50 nº4; 215-223 MAHAJAN AN. Formulation and Evaluation of Timed Delayed…  220 
Effect of different tablet plug material on lag time 
In order to identify proper plug material, the lag times of delayed release capsule with different 
erodible tablet plug materials were investigated. The water soluble polymer polyethylene oxide 
appeared attractive as erodible plug materials because of their frequent use in hydrophilic matrix 
tablets. Three different molecular weights of polyethylene oxide(PEO), (WSR N-10, WSR N-80, and 
WSR N-750) were evaluated. The results are shown in Figure 3. When comparing three different 
molecular weight of PEO within this study it was found that capsules prepared using higher molecular 
weight polyethylene oxide resulted in longer lag times. Depending on the molecular weight of PEO, 
the polymer matrix degrades at different rates by erosion/dissolution of the polymer
17. Further the 
system with PEO WSR N-10 was less sensitive to the amount of PEO in the erodible plug, which 
might be important from a manufacturing point of view. This could be very advantageous, because a 
deviation of the amount of PEO in the plug would result in only relatively small changes in lag time 
and consequently reproducible drug release profiles, with rapid and complete drug release. Therefore 
WSR N-10 was selected for further study as a plug material for the preparation of the erodible tablet 
plug.  
Figure 3: Effect of different tablet plug material on lag time of timed delayed capsule device 
 
Effect of WSR N-10 content in erodible tablet plug 
Dissolution profiles of timed delayed capsule device containing different content of WSR N-10 in the 
erodible tablets are shown in Figure 4.The lag time (t10) for the formulations A1, A6, A7, A8, A9 and 
A10 was 120mins, 153mins, 195mins, 252mins, 307mins and 351mins respectively. The release 
profiles revealed time delayed released characteristics. Increasing the concentration of PEO WSR N-
10 in tablet plug resulted in increase in lag time. 
Visual observation during the dissolution process revealed the detachment of gelled plumes from the 
erodible tablet surface. Eventually, at a point at which only the smallest of gel layers remained, water 
ingress then followed leading to expansion of the expulsion excipient (L-HPC) and pushes the 
terbutaline sulphate tablet towards the open end of the hard gelatin capsule body. L-HPC has 
previously been shown to have excellent expansion potential for application such as pulsatile capsule 
device
18 and enables complete drug expulsion from Pulsincap formulation
19 and was successfully 
employed as an expulsion system in these studies. In accordance with the chronomodulated therapy of 
asthma, the lag time criterion of 5 hours was satisfied by formulation A11. 
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Figure 4: Effect of WSR N-10 content in the erodible tablet plug on drug release of timed delayed 
capsule device 
 
  
Effect of tablet plug hardness on drug release 
Figure 5: Effect of tablet plug hardness on drug release (Batch A1) 
 
To study the effect of tablet hardness on drug release, erodible tablet hardness (Batch A1) varied 
between 4-6 kg/cm
2.The results are shown in Figure 5. The similarity factor (ƒ2) was used to evaluate 
the drug release. 
 
  
Where Rj and Tj are the average percentage of drug released from the three test tablets and three 
reference tablets at each point time j and n are the number of time points tested. Two curves are 
thought to be statistically similar if the ƒ2 value was above 50. The similarity factor of dissolution 
curve for different tablet hardness was 68.04. The results concluded that tablet hardness within the 
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range of 4-6kg/cm
2 did not significantly influence the drug release. 
Effect of erodible tablet plug weight on lag time 
Maintaining the same composition of erodible tablet (Batch A7), plugs of different weights such as 
110, 150 and 190mg were evaluated for lag time. The relationship between plug weight and lag time is 
shown in Figure 6. A good correlation was observed between them (r
2=0.950). Increasing tablet plug 
weight seemed to prolong lag time since the time required to complete the dissolution or erosion of the 
tablet plug would be longer. This suggested that the lag time could also be adjusted by changing the 
plug weight. 
Figure 6: Influence of the Erodible Plug Weight on the Lag Time (Batch A7) 
 
CONCLUSION 
A timed delayed capsule device for chronotherapeutic delivery of terbutaline sulphate was 
successfully developed. In accordance with the chronomodulated therapy of asthma, the lag time 
criterion of 5 hours was satisfied by formulation A11. The dosage form can be taken at bed time and 
will release the contents in the early morning hours when asthma attacks are more prevalent. 
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